Revisiting Phage Therapy for Antibiotic-Resistant Superbugs

We’re revisiting this 2017 episode—with updates! The episode is an interview with Robert T. "Chip" Schooley, MD, a professor of medicine in the Division of Infectious Diseases and Global Public Health at the University of California, San Diego, and codirector of the school’s Center for Innovative Phage Applications and Therapeutics. Dr Schooley discusses the unique events that led to the first use of intravenous phage therapy in North America. Stay tuned to the end for an update on phage therapy and on Thomas Patterson, the patient who received the lifesaving treatment. Related Content:

• Phage Therapy’s Role in Combating Antibiotic-Resistant Pathogens
• As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest